CCL5 and neoplasm: In addition, CCL5 positivity in the IC was an independent prognostic marker for RFS in the following subgroups: tumor stage pT3 + 4 (RR = 2.38; p < 0.001) and no chemotherapy (RR = 2.32; p = 0.001).